This topic contains a solution. Click here to go to the answer

Author Question: The nurse is preparing to admit a 4-year-old child with chronic benign neutropenia. What clinical ... (Read 109 times)

mcmcdaniel

  • Hero Member
  • *****
  • Posts: 550
The nurse is preparing to admit a 4-year-old child with chronic benign neutropenia. What clinical features of chronic benign neutropenia should the nurse recognize? (Select all that apply.)
 
  a. Gingivitis is present.
  b. Anemia is not present.
  c. Monocytosis is present.
  d. It has an autosomal recessive pattern.
  e. Treatment is by bone marrow transplantation.

Question 2

The nurse is caring for a 12-year-old child with -thalassemia. What clinical manifestations should the nurse expect to observe? (Select all that apply.)
 
  a. Anorexia
  b. Unexplained fever
  c. Enlarged spleen or liver
  d. Bronzed, freckled complexion
  e. Precocious sexual development



Related Topics

Need homework help now?

Ask unlimited questions for free

Ask a Question
Marked as best answer by a Subject Expert

chreslie

  • Sr. Member
  • ****
  • Posts: 307
Answer to Question 1

ANS: A, B, C
The clinical features of chronic benign neutropenia include gingivitis, no anemia, and monocytosis. It is not inherited, and because it is benign, it does not require treatment except antibiotics as indicated.

Answer to Question 2

ANS: A, B, C, D
The clinical manifestations of -thalassemia include anorexia; unexplained fever; an enlarged spleen or liver; and a bronzed, freckled complexion. There is delayed sexual maturation, not precocious.




mcmcdaniel

  • Member
  • Posts: 550
Reply 2 on: Jun 28, 2018
Thanks for the timely response, appreciate it


nanny

  • Member
  • Posts: 313
Reply 3 on: Yesterday
Wow, this really help

 

Did you know?

Acetaminophen (Tylenol) in overdose can seriously damage the liver. It should never be taken by people who use alcohol heavily; it can result in severe liver damage and even a condition requiring a liver transplant.

Did you know?

Bisphosphonates were first developed in the nineteenth century. They were first investigated for use in disorders of bone metabolism in the 1960s. They are now used clinically for the treatment of osteoporosis, Paget's disease, bone metastasis, multiple myeloma, and other conditions that feature bone fragility.

Did you know?

More than 150,000 Americans killed by cardiovascular disease are younger than the age of 65 years.

Did you know?

Individuals are never “cured” of addictions. Instead, they learn how to manage their disease to lead healthy, balanced lives.

Did you know?

Persons who overdose with cardiac glycosides have a better chance of overall survival if they can survive the first 24 hours after the overdose.

For a complete list of videos, visit our video library